Showing 4471-4480 of 9103 results for "".
- Inmagene's OX40 mAb Enters POC Study in ADhttps://practicaldermatology.com/news/inmagenes-ox40-mab-enters-poc-study-in-ad/2461934/The first patient has been dosed in a global multicenter proof-of-concept (POC) study of Inmagene Biopharmaceuticals’ IMG-007 in adults with moderate-to-severe atopic dermatitis (AD). The objective of the study is to assess the safety, pharmacokinetics, and efficacy of
- Regenerative Medicine in Action: Turn Bio's ERA Technology Reprograms Skin Cellshttps://practicaldermatology.com/news/regenerative-medicine-in-action-turn-bios-era-technology-reprograms-skin-cells/2461930/Reprogramming with Turn Bio's ERA technology can rejuvenate cells within the extracellular matrix (ECM), resulting in changes related to improved skin quality and structure, according to a presentation at the AAD 2023 Innovation Academy in Tampa, Fla. ERA reprogramming tec
- Angina Drug Ranolazine Improves the Efficacy of Current Treatments for Melanoma in Mouse Modelshttps://practicaldermatology.com/news/angina-drug-ranolazine-improves-the-efficacy-of-current-treatments-for-melanoma-in-mouse-models/2461926/The heart drug ranolazine may improve the efficacy of current therapies for melanoma in mouse models of this disease, according to research out of Navarrabiomed Biomedical Research Center, the Institute of Neurosciences CSIC-UMH, and IRB Barcelona. The development of future clinical tri
- DermaSensor Device Can Help Detect Skin Cancer Across Skin Toneshttps://practicaldermatology.com/news/dermasensor-device-can-help-detect-skin-cancer-across-skin-tones/2461924/DermaSensor's handheld Elastic Scattering Spectroscopy (ESS) device can help detect skin cancer in patients across different Fitzpatrick skin types, according to new research presented at the 2023 American Academy of Dermatology (AAD) Innovation Academy meeting. DermaSensor is desig
- The Dermatology Practice of the Future: AI-Powered Piction Health Dermatology Launches in Massachusettshttps://practicaldermatology.com/news/the-dermatology-practice-of-the-future-ai-powered-piction-health-dermatology-launches-in-mass/2461923/Piction Health Dermatology, an AI-enabled dermatology virtual clinic, is now open for Massachusetts residents. Piction's virtual clinic merges artificial intelligence (AI) with the expertise of board-certified dermatologists. Patients complete a short medical in
- Arcutis, Huadong Announce Strategic Collab and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asiahttps://practicaldermatology.com/news/arcutis-huadong-announce-strategic-collab-and-licensing-agreement-for-topical-roflumilast-in-greater-china-and-southeast-asia/2461921/Arcutis Biotherapeutics, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co. have entered into a strategic c
- Acclaro Medical Rolls Out UltraClear Laser-Coring Technologyhttps://practicaldermatology.com/news/acclaro-medical-rolls-out-ultraclear-laser-coring-technology/2461920/Acclaro Medical is rolling out UltraClear Laser-Coring at the 2023 AAD Innovation Academy in Tampa, Fla. UltraClear, a cold, ablative fiber laser, enables tissue coring to improve deep wrinkles, deep scars, and other age-related issues on all skin types with minimal disco
- Positive Topline Data Seen in Phase II Trial of LNK01001 in ADhttps://practicaldermatology.com/news/positive-topline-data-seen-in-phase-ii-trial-of-lnk01001-in-ad/2461916/Lynk Pharmaceuticals Co., Ltd.’s LNK01001 performed well in a Phase II clinical trial for the treatment of atopic dermatitis (AD), according to positive topline data from the Company. LNK01001 is a highly selective JAK1 inhibitor that blocks JAK1 without crossing over onto ot
- August Is Psoriasis Action Month: Experts Offer Treatment Tipshttps://practicaldermatology.com/news/august-is-psoriasis-action-month-experts-offer-treatment-tips/2461915/August is Psoriasis Action Month and serves as a good time to make sure that your patients are being adequately treated with available therapies, psoriasis experts tell DermWire. Psoriasis is common, affecting 7.5 million in the US, one-third of whom are candidates for either
- Vacation Tanning Linked to Acute Changes in Skin Microbiomehttps://practicaldermatology.com/news/vacation-tanning-linked-to-acute-changes-in-skin-microbiome/2461912/Sun-seeking behaviors while on vacation may affect the skin’s microbiome, new research suggests. Prior to vacations to sunny destinations, which lasted at least seven days, the researchers analyzed participants’ skin. On day one, 28, and 84 post-holiday, participants’